JDB153
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for JDB153, covering 2025-07-20 to 2025-09-16. Get the full timeline:
Most recent: Clinical Trial Update: JDB153 Combined With Serplulimab for Pancreatic Cancer After Standard Treatment Failure [Phase 1, Phase 2]